The Leadership Team at Immunovant is responsible for shaping the strategic direction of the company and ensuring effective collaboration across all functions. This team, comprising key executives in areas such as regulatory affairs, development, marketing, quality, finance, and legal, works together to advance the development of IMVT-1401 while navigating the complexities of the biopharmaceutical landscape to achieve the company's mission of addressing autoimmune diseases.
Jody Roth
VP, Global Regulatory Affairs
Julia G. Butchko
Chief Development Officer
Lauren Schrier
VP, Marketing
Lesa Valentine
VP, Quality
Mark Levine
Chief Legal Officer & Corporat...
Peter Salzmann
Chief Executive Officer
Renee Barnett
Chief Financial Officer
William Macias
Chief Medical Officer
Yan Zheng
VP, Biostatistics & Programmin...
View all